And you will be a traded organization publicly.

Abbott to sell its developed markets branded generics pharmaceuticals business to Mylan Abbott announced today that it will sell its developed markets branded generics pharmaceuticals business to Mylan for equity ownership of a newly formed entity that may combine Mylan’s existing business and Abbott’s developed markets pharmaceuticals business, and you will be a traded organization publicly. This represents a value of approximately $5 buy meds online .3 billion predicated on Mylan’s closing stock price on Friday. The developed markets portion of this business generated approximately $2 billion in product sales in 2013.